SCHEMBL7984283

SCHEMBL7984283

O=c1nc(-c2ccc(F)cc2)[nH]c2ncn(Cc3ccc(F)cc3)c12

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 3/20 0.43
PARN O95453 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 1/20 0.41
ACP1 P24666 1/20 0.41
MET P08581 2/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP11B2 P19099 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
P2RX7 Q99572 1/20 0.38
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985168 0.94 KMT2A (0.46) CNOT7PARNACP1KDM4EALDH1A1
SCHEMBL7974508 0.94 CNOT7 (0.51) CNOT7PARNSMN1; SMN2ACP1LMNA
SCHEMBL7986522 0.94 CNOT7 (0.48) CNOT7PARNSMN1; SMN2HTTACP1
SCHEMBL7985279 0.93 CNOT7 (0.49) CNOT7PARNSMN1; SMN2HTTLMNA
SCHEMBL7987364 0.91 TNKS (0.46) CNOT7PARNSMN1; SMN2HTTACP1
SCHEMBL7988644 0.89 GRIN1 (0.42) CNOT7PARNSMN1; SMN2ACP1ALDH1A1
SCHEMBL7988736 0.89 ACP1 (0.45) CNOT7PARNSMN1; SMN2HTTACP1
SCHEMBL7988820 0.88 MAPK1 (0.48) CNOT7PARNSMN1; SMN2HTTACP1
SCHEMBL7989422 0.87 CNOT7 (0.47) CNOT7PARNSMN1; SMN2HTTCYP11B2
SCHEMBL7974418 0.87 CNOT7 (0.39) CNOT7PARNSMN1; SMN2HTTACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed